Literature DB >> 7843329

Biological activity of secondary metabolites from Bupleurum salicifolium (Umbelliferae).

J A González1, A Estévez-Braun, R Estévez-Reyes, I L Bazzocchi, L Moujir, I A Jimenez, A G Ravelo, A G González.   

Abstract

Secondary metabolites from Bupleurum salicifolium were tested against viruses, Gram-positive and Gram-negative bacteria, the yeast Candida albicans, the nematodes Globodera pallida and G. rostochiensis, the insect Spodoptera littoralis and the crustacean Artemia salina. These compounds were also tested against tumoral and non-tumoral cell lines. The polyacetylene 8S-heptadeca-2(Z)-9(Z)-diene-4,6-diyne-1,8-diol exhibited toxicity for A. salina and specific antibiotic activity against Gram-positive bacteria. Nine of the lignans and one coumarin showed toxicity for A. salina, and the lignans bursehernin and matairesinol inhibited the hatching of the two nematode species. These are the first lignans that have been reported as affecting phytoparasitic nematodes, and the first natural products known to have an effect on the hatching of G. pallida. Lignans may play a role in the defence mechanisms of potato plants, as allelopathic substances acting against cyst-forming nematodes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7843329

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  3 in total

1.  Phytotoxic and antifungal compounds from two Apiaceae species, Lomatium californicum and Ligusticum hultenii, rich sources of Z-ligustilide and apiol, respectively.

Authors:  Kumudini M Meepagala; George Sturtz; David E Wedge; Kevin K Schrader; Stephen O Duke
Journal:  J Chem Ecol       Date:  2005-07       Impact factor: 2.626

2.  Antimicrobial and antiproliferative activity of Athamanta sicula L. (Apiaceae).

Authors:  Vita Di Stefano; Rosa Pitonzo; Domenico Schillaci
Journal:  Pharmacogn Mag       Date:  2011-01       Impact factor: 1.085

Review 3.  Genus Bupleurum: a review of its phytochemistry, pharmacology and modes of action.

Authors:  Mohamed L Ashour; Michael Wink
Journal:  J Pharm Pharmacol       Date:  2010-11-16       Impact factor: 3.765

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.